Essential History Questions for a Patient with Short Cervix
When evaluating a patient with a short cervix, your primary focus should be determining eligibility for vaginal progesterone therapy and identifying risk factors that predict preterm birth—specifically, you must establish whether there is a history of prior spontaneous preterm birth, as this fundamentally changes management.
Critical Historical Elements to Obtain
1. Prior Obstetric History (Most Important)
- History of spontaneous preterm birth: This is the single most critical question, as patients WITH prior spontaneous preterm birth may benefit from cerclage, while those WITHOUT prior spontaneous preterm birth should NOT receive cerclage 1
- Number and gestational age of all previous deliveries: Parous women have lower risk of short cervix complications than nulliparous women 2
- History of previous miscarriages/abortions: Women with prior abortions have significantly increased risk of short cervix (p < .001) 2
- Circumstances of any prior preterm births: Distinguish spontaneous from indicated preterm births
2. Current Pregnancy Characteristics
- Singleton vs. multiple gestation: Management differs completely—progesterone, pessary, and cerclage are NOT recommended for twins with short cervix 1
- Exact gestational age: Vaginal progesterone is recommended for cervical length ≤20 mm diagnosed before 24 weeks 1
- Presence of symptoms: Confirm the patient is truly asymptomatic—no contractions, bleeding, or rupture of membranes, as symptomatic patients require different management 1
3. Risk Factors for Short Cervix
- Body Mass Index (BMI): Women with BMI ≥30 have significantly increased risk of short cervix (p < .001) 2
- Current cervical dilation on exam: Ask if physical examination has revealed any cervical dilation, as cervical length ≤11 mm predicts ≥1 cm dilation with 75% sensitivity 3
4. Contraindications to Treatment
- Allergies to progesterone formulations
- History of thromboembolic disease (relative consideration for progesterone)
- Cervical procedures or surgeries: Prior cone biopsy, LEEP, or other cervical procedures
Key Clinical Pitfalls
Do not assume all short cervix patients are the same. The evidence shows that cervical length ≤10 mm carries substantially higher risk than 21-25 mm, with the ≤10 mm group having the shortest time to delivery (median 10 weeks vs. 13.2 weeks for 21-25 mm) 4. However, even with cervical length ≤10 mm at 23-28 weeks, delivery within 2 weeks remains extremely uncommon (0.8%) 4.
Avoid the trap of universal cerclage placement. In patients without prior spontaneous preterm birth, cerclage is specifically NOT recommended even with cervical length 10-25 mm in the absence of cervical dilation 1. This represents a Grade 1B recommendation against cerclage in this population.
Remember that 17-alpha hydroxyprogesterone caproate (17-OHPC) should NOT be prescribed for short cervix treatment, including compounded formulations, as it lacks efficacy 1. Only vaginal progesterone has proven benefit.
Management Algorithm Based on History
Cervical length ≤20 mm + singleton + no prior spontaneous preterm birth + diagnosed before 24 weeks → Prescribe vaginal progesterone (Grade 1A) 1
Cervical length 21-25 mm + singleton → Consider vaginal progesterone via shared decision-making (Grade 1B) 1
Twin gestation with short cervix → No progesterone, pessary, or cerclage outside clinical trials (Grade 1B) 1
History of prior spontaneous preterm birth → Different management pathway; consider cerclage in appropriate candidates 5
The history you obtain directly determines whether the patient receives evidence-based therapy that reduces preterm birth risk by 27-30% 5 or is inappropriately treated with ineffective interventions.